Atrial fibrillation Trials in London, United Kingdom
Conditions / Atrial fibrillation / London, United Kingdom
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
87 total trials for this combination
Showing top 10 of 87 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT02244853 | Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease | UNKNOWN | — |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT06072287 | The Living With a Long-Term Condition Study | UNKNOWN | — |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT04045665 | Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | RECRUITING | PHASE3 |
| NCT01944397 | A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation | UNKNOWN | — |
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |